We found that FK866 and CHS828, two distinct NAMPT inhibitors, increased the TMZ-induced apoptosis and necrosis, enhanced the TMZ-induced caspase-1, caspase-3, and caspase-9 activities, and augmented the TMZ-induced oxidative stress in glioblastoma cells. Here, NAMPT is linked to glioblastoma.